ARCHIVES

Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010

Foon To Direct Barrett Center; Hundahl Leads Commission

March 5, 1999

Susan Horwitz Succeeds Waun Ki Hong As AACR President

April 12, 2002

Cancer Advocacy: Survivors, Supporters Gather to Light Candles, Curse the Darkness

October 1, 1999

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987

Foti Receives Del Duca Award; Wake Forest To Hire 60 Faculty.

February 11, 2000